|
Journal of Child and Adolescent Psychopharmacology
Use and Persistence of Pharmacotherapy for Elementary School Students with Attention-Deficit/Hyperactivity Disorder
To cite this article:
Regina Bussing, Bonnie T. Zima, Dana Mason, Wei Hou, Cynthia Wilson Garvan, Steven Forness.
Journal of Child and Adolescent Psychopharmacology.
2005,
15(1): 78-87.
doi:10.1089/cap.2005.15.78.
Regina Bussing, M.D.Department of Psychiatry, University of Florida, Gainesville, Florida. Bonnie T. Zima, M.D.Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, Los Angeles, California. Dana Mason, B.S.Department of Psychiatry, University of Florida, Gainesville, Florida. Wei Hou, M.S.Department of Biostatistics, University of Florida, Gainesville, Florida. Cynthia Wilson Garvan, Ph.D.Department of Biostatistics, University of Florida, Gainesville, Florida. Steven Forness, Ed.D.Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, Los Angeles, California. Objective: The aim of this study was to describe rates of attention-deficit/hyperactivity disorder (ADHD) medication treatment and relevant school services use during a 2-year period, and to examine independent predictors of these interventions. Method: Parent and child interviews (n = 266) and follow-up 12-month telephone surveys (n = 220) were conducted among a high-risk sample, selected from a districtwide, stratified, random sample of elementary-school students screened for ADHD risk. Medication treatment status and school services use were assessed from multiple sources, and their predictors were identified by logistic regression modeling, adjusting for sociodemographic and parental characteristics, as well as clinical-need variables. Results: Approximately one third (35%) of the children received ADHD medications during a 2-year period, and of those treated at Time 2, approximately one third (36%) were no longer on medications at Time 3. Boys were more than twice as likely to receive ADHD medication as girls. Approximately one quarter (28%) of the children accessed school services and continued their use over 2 years. African-American youths were more likely to receive school services than were Caucasian children. Conclusions: In this elementary school–district high-risk sample, care for ADHD was remarkable for underuse and attrition of medication treatment, as well as poor linkage to relevant school services. Interventions to improve ADHD care should include supports to access and sustain medication treatment, as well as link with school services, especially for girls.  This paper was cited by:African-American Teenagers’ Stories of Attention Deficit/Hyperactivity Disorder Mirka Koro-Ljungberg, Regina Bussing, Pamela Williamson, JeffriAnne Wilder, Terry Mills Journal of Child and Family Studies. Sep 2008, Vol. 17, No. 4: 467-485 CrossRef Psychotropic Medication Use in Children and Adolescents: A Study from France Christine Sevilla–Dedieu, Viviane Kovess–Masféty Journal of Child and Adolescent Psychopharmacology. Jun 2008, Vol. 18, No. 3: 281-289 Abstract | Full Text PDF | Reprints & PermissionsPublic Knowledge and Assessment of Child Mental Health Problems BERNICE A. PESCOSOLIDO, PETER S. JENSEN, JACK K. MARTIN, BREA L. PERRY, SIGRUN OLAFSDOTTIR, DANIELLE FETTES Journal of the American Academy of Child & Adolescent Psychiatry. Apr 2008, Vol. 47, No. 3: 339-349 CrossRef Once-Daily Multilayer-Release Methylphenidate in a Double-Blind, Crossover Comparison to Immediate-Release Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder Margaret Weiss, Lily Hechtman, Atilla Turgay, Umesh Jain, Declan Quinn, Tahira S. Ahmed, Timothy Yates, Joseph L. Reiz, Graeme A.E. Donnelly, Zoltan Harsanyi, Andrew C. Darke Journal of Child and Adolescent Psychopharmacology. Nov 2007, Vol. 17, No. 5: 675-688 Abstract | Full Text PDF | Reprints & PermissionsInvestigating ADHD Treatment Trajectories: Listening to Families?? Stories About Medication Use Laurel K. Leslie, Dena Plemmons, Amy R. Monn, Lawrence A. Palinkas Journal of Developmental & Behavioral Pediatrics. Jul 2007, Vol. 28, No. 3: 179-188 CrossRef Long-term treatment of children and adolescents with attention-deficit/ hyperactivity disorder (ADHD) Lily Hechtman Current Psychiatry Reports. Nov 2006, Vol. 8, No. 5: 398-408 CrossRef Atomoxetine in clinical practice Margaret D Weiss, Adil Virani, Michael Wasdell, Lorelei Faulkner, Kathleen Rea, Roger D Freeman, Gabrielle Weiss, Veena Jokhani Future Neurology. Jun 2006, Vol. 1, No. 3: 249-258 CrossRef
|
|